The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% by 2025


   January 13, 2021
According to a new market report published by Lucintel, the future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. In this market, instruments and comsumables are the major products of hematology diagnostic. Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.

Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.

North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.

Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation are among the major suppliers in the global hematology diagnostic market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global hematology diagnostic market by product, test, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Hematology Diagnostic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Instruments


  • Consumables


By Test [Value ($ Million) shipment analysis for 2014 – 2025]:



  • CBC


    • Hemoglobin


    • Hematocrit


    • RBC




  • WBC


  • Reticulocytes


  • Platelet Function


  • CRP


  • Neutrophil Function


  • Bone Marrow


  • DPG


 

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Hospitals


  • Diagnostic Labs


  • Others


By Region [Value ($ Million) shipment analysis for 2014 – 2025]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United Kingdom


  • Spain


  • Germany


  • France




  • Asia Pacific




  • China


  • India


  • Japan




  • The Rest of the World




  • Brazil


 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti